Skip to content

MAtilda Hospital and Chinese University Shock Wave therapy for Ischemic Myocardium (MACUSWIM)

MAtilda Hospital and Chinese University Shock Wave therapy for Ischemic Myocardium (MACUSWIM)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001035
Enrollment
Unknown
Registered
2010-07-06
Start date
2008-02-04
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Cardiomyopathy

Interventions

Two groups:Shock Wave therapy for 2 years
0:60 stable chronic angina patients with either coronary artery disease that is not amenable for revascularization or triple vessel coronary artery disease awaiting coronary artery bypass grafting wil
0:After randomization, they will then undergo ultrasound shock wave therapy for 20 minutes, three times a week on either the first, fifth, and ninth week of the study or the 18th, 23rd, and 27th week
0:MRI heart, Exercise testing, and echocardiography would be performed at 6 months and coronary artery bypass grafting would be performed at 6 months. Follow up questionnaire and clinical assessment w

Sponsors

Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patient is male or female between 18 and 85 years of age on day of signing informed consent; 2. Contraception for female patients who are of reproductive potential: a femalepatient who is of reproductive potential agrees to remain abstinent or use (or havetheir partner use) 2 acceptable methods of birth control for the duration of the study.An acceptable method of birth control is defined as: intrauterine device (IUD), diaphragm with spermicide, contraceptive sponge, condom, vasectomy. Note: Female patients who have reached menopause, undergone hysterectomy, bilateral oophorectomy, or bilateral tubal ligation are eligible without the use ofcontraceptives; 3. Patients with coronary angiography demonstrating coronary anatomy not amenable to revascularization or suitable for routine elective coronary artery bypass grafting with impaired LVEF < 40% and with substantial viable reversible myocardial ischemia in at least one vascular territory on MRI.

Exclusion criteria

Exclusion criteria: 1. Patient is male or female between 18 and 85 years of age on day of signing informed consent; 2. Contraception for female patients who are of reproductive potential: a femalepatient who is of reproductive potential agrees to remain abstinent or use (or havetheir partner use) 2 acceptable methods of birth control for the duration of the study.An acceptable method of birth control is defined as: intrauterine device (IUD), diaphragm with spermicide, contraceptive sponge, condom, vasectomy. Note: Female patients who have reached menopause, undergone hysterectomy, bilateral oophorectomy, or bilateral tubal ligation are eligible without the use ofcontraceptives; 3. Patients with coronary angiography demonstrating coronary anatomy not amenable to revascularization or suitable for routine elective coronary artery bypass grafting with impaired LVEF < 40% and with substantial viable reversible myocardial ischemia in at least one vascular territory on MRI.

Design outcomes

Secondary

MeasureTime frame
Improved CCS angina grade.;Improved 6 minute walk.;Improved SF-36.;

Primary

MeasureTime frame
Improved Exercise duration on standard Bruce Protocol Exercise test;Improved angina frequency.;

Countries

China

Contacts

Public ContactCheuk Man Yu / Sheung Poon
poonsps@yahoo.com.hk+852 2632 1752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026